Form D · Biotechnology
e-Nicotine Technology, Inc.
Draper, UT · CIK 0001584922
Offering snapshot reported Oct 29, 2014 · SEC filing
- Reported sold
- $400K Offering amount: $1.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2014 | Initial | $400,000 | No comparison | 17 | SEC filing |
| Oct 24, 2013 | Amendment | $3,977,587 | $1,367,087vs Aug 29, 2013 | 28 | SEC filing |
| Aug 29, 2013 | Initial | $2,610,500 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227311
Source: Form D, filed Oct 29, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Brenner | Director |
| Fraser Bullock | Director |
| Michael Hufford | Director, Executive |
| Christopher B Munday | Director |
| Don Watkins | Director |
| Martin Wensley | Executive |
| Jeffrey Williams | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13512 S. Aintree Ave.
Draper, UT, 84020
Draper, UT, 84020